Studies have shown that in patients with diabetic nephropathy, hyperglycemia can activate NLRP3, which coexists with ASC and pro-caspase-1 to form the NLRP3 inflammasome, and then activates caspase-1. This evidence concerns the gene CASP1 and diabetic kidney disease.